W USA zalecają szczepionkę na COVID-19 dla każdego. Eksperci: Amerykanie
nie chcą się szczepić
https://www.medonet.pl/koronawirus,w-usa-zalecaja-szczepionke-na-covid-19-dla-kazdego--eksperci--sytuacja-jest-powazna--a-ludzie-sie-buntuja,artykul,63395865.html
Niech się szczepią
Robert Kennedy zna odpowiedź
https://www.medalerts.org/vaersdb/findfield.php?EVENTS=on&PAGENO=3707&PERPAGE=10&ESORT=&REVERSESORT=&VAX=(COVID19)&DIED=Yes
Found 37,154 cases where Vaccine is COVID19 and Patient Died
Government Disclaimer on use of this data
Case Details
This is page 3707 out of 3,716
Result pages: prev 3698 3699 3700 3701 3702 3703 3704 3705 3706 3707
3708 3709 3710 3711 3712 3713 3714 3715 3716 next
VAERS ID: 2756965 (history)
Form: Version 2.0
Age:
Sex: Male
Location: Foreign
Vaccinated: 0000-00-00
Onset: 0000-00-00
Submitted: 0000-00-00
Entered: 2024-03-26
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -
Administered by: Unknown Purchased by: ?
Symptoms: Pulmonary oedema
SMQs:, Cardiac failure (narrow), Haemodynamic oedema, effusions and
fluid overload (narrow)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: SAXIB
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2757097 (history)
Form: Version 2.0
Age:
Sex: Male
Location: Foreign
Vaccinated: 2021-10-26
Onset: 2021-12-01
Days after vaccination: 36
Submitted: 0000-00-00
Entered: 2024-03-26
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH FG6270 /
3 - / OT
Administered by: Other Purchased by: ?
Symptoms: Asthenia, SARS-CoV-2 test, Thrombocytopenia
SMQs:, Haematopoietic thrombocytopenia (narrow), Systemic lupus
erythematosus (broad), Guillain-Barre syndrome (broad), Drug reaction
with eosinophilia and systemic symptoms syndrome (broad),
Immune-mediated/autoimmune disorders (broad), COVID-19 (broad)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 2022-05-07
Days after onset: 156
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2757298 (history)
Form: Version 2.0
Age: 74.0
Sex: Female
Location: Foreign
Vaccinated: 2021-12-02
Onset: 2022-03-01
Days after vaccination: 89
Submitted: 0000-00-00
Entered: 2024-03-27
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / IM
Administered by: Unknown Purchased by: ?
Symptoms: Glioblastoma
SMQs:, Non-haematological malignant tumours (narrow)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2757467 (history)
Form: Version 2.0
Age:
Sex: Female
Location: Foreign
Vaccinated: 2021-05-12
Onset: 2023-06-28
Days after vaccination: 777
Submitted: 0000-00-00
Entered: 2024-03-28
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 - / SYR
Administered by: Unknown Purchased by: ?
Symptoms: Blood lactic acid, Death neonatal, Encephalopathy neonatal,
Neonatal asphyxia, Neonatal behavioural syndrome, pH body fluid
SMQs:, Acute central respiratory depression (broad), Noninfectious
encephalopathy/delirium (narrow), Neonatal disorders (narrow),
Respiratory failure (broad)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 2023-06-30
Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Drug
exposure before pregnancy
Allergies:
Diagnostic Lab Data: Test Date: 202306; Test Name: Lactates; Result
Unstructured Data: lactates at 18; Test Date: 202306; Test Name: pH;
Result Unstructured Data: 6.79; Test Date: 202306; Test Name: pH; Result
Unstructured Data: 7.04
CDC Split Type: CHMODERNATX, INC.MOD20247
Write-up: Early neonatal death; Severe asphyxia with multiorgan
involvement; Hypoxic-ischaemic encephalopathy; Poor neonatal adaptation
syndrome; This regulatory authority case was reported by an other health
care professional and describes the occurrence of NEONATAL ASPHYXIA
(Severe asphyxia with multiorgan involvement), ENCEPHALOPATHY NEONATAL
(Hypoxic-ischaemic encephalopathy), NEONATAL BEHAVIOURAL SYNDROME (Poor
neonatal adaptation syndrome) and DEATH NEONATAL (Early neonatal death)
in a female neonate of an unknown age exposed to mRNA-1273 (COVID-19
Vaccine Moderna) , while the mother received the product for COVID-19
immunisation. MEDICAL HISTORY (Parent): The mother''s past medical
history included COVID-19 on 29-Dec-2021, Pregnancy (patient with a
history of vaginal delivery at 38 weeks of amenorrhea to a 3100 g boy)
and Pregnancy (second pregnancy that ends with a caesarean section
following intrauterine fetal death at the 29th week of amenorrhea due to
placental abruption.). MEDICAL HISTORY (Patient): The patient''s past
medical history included Drug exposure before pregnancy on 12-May-2021.
On 12-May-2021, the mother received first dose of mRNA-1273 (COVID-19
Vaccine Moderna) (Intramuscular use) 1 dosage form. On 15-Jun-2021,
received second dose of mRNA-1273 (COVID-19 Vaccine Moderna)
(Intramuscular use) dosage was changed to 1 dosage form. Last menstrual
period and estimated date of delivery were not provided. On 28-Jun-2023,
the neonate was diagnosed with NEONATAL ASPHYXIA (Severe asphyxia with
multiorgan involvement) (seriousness criterion medically significant),
ENCEPHALOPATHY NEONATAL (Hypoxic-ischaemic encephalopathy) (seriousness
criterion medically significant) and NEONATAL BEHAVIOURAL SYNDROME (Poor
neonatal adaptation syndrome) (seriousness criterion medically
significant). The neonate was diagnosed with DEATH NEONATAL (Early
neonatal death) on 30-Jun-2023. The Neonate was exposed to mRNA-1273
(COVID-19 Vaccine Moderna) during pregnancy. The cesarean delivery
occurred, which was reported as Premature. For neonate 1, with an APGAR
score of 0, 0 and 1 at (1, 5, 10 minutes). The outcome was reported as
Pre-Term Birth w Complications. Patient had an emergency caesarean
section at 33 4/7 weeks of amenorrhea from a bichorial-biamniotic twin
pregnancy for placental abruption and fetal bradycardia. The mother had
hemorrhagic shock due to placental detachment. Blood loss was estimated
at 3300 ml. There was severe disseminated intravascular coagulation in a
context of placental abruption, an acquired deficiency of severe
coagulation factors, consumer thrombocytopenia with nadir at 80 mg/l and
post-partal anemia with nadir at 93 g/l. J1 showed good neonatal
adaptation. He was initially hospitalized in neonatology on CPAP, which
may be weaned later. On 28-Jun-2023, NEONATAL ASPHYXIA (Severe asphyxia
with multiorgan involvement) and ENCEPHALOPATHY NEONATAL
(Hypoxic-ischaemic encephalopathy) had resolved. On 30-Jun-2023,
NEONATAL BEHAVIOURAL SYNDROME (Poor neonatal adaptation syndrome) had
resolved. The neonate died on 30-Jun-2023. The cause of death was not
reported. It is unknown if an autopsy was performed. DIAGNOSTIC RESULTS
(normal ranges are provided in parenthesis if available): In June 2023,
Blood lactic acid: lactates at 18. In June 2023, pH body fluid: 6.79 and
7.04. For mRNA-1273 (COVID-19 Vaccine Moderna) (Transplacental), the
reporter considered NEONATAL ASPHYXIA (Severe asphyxia with multiorgan
involvement), ENCEPHALOPATHY NEONATAL (Hypoxic-ischaemic
encephalopathy), NEONATAL BEHAVIOURAL SYNDROME (Poor neonatal adaptation
syndrome) and DEATH NEONATAL (Early neonatal death) to be not related.
Concomitant and treatment medications were not reported. Patient showed
poor neonatal adaptation and had severe asphyxia with hypoxic-ischaemic
encephalopathy and multiorgan involvement. Despite immediate
resuscitation and a recovery of the heart rhythm at 15 minutes of life,
the clinical neurological evolution was unfavorable. The newborn died
after 2 days of life. WWID was reported as CH-SM-2024-11368. Company
Comment: This regulatory authority case concerns a female neonate of an
unknown age, who experienced the serious (due to Fatal and medically
significant) unexpected event of Death neonatal, the serious (due to
Medically significant) unexpected events of Neonatal asphyxia,
Encephalopathy neonatal and Neonatal behavioural syndrome. The events
occurred almost 2 years after a dose of mRNA-1273 vaccine received by
the mother as the second dose of COVID-19 vaccination schedule. the
mother of the baby had an emergency caesarean section at 33 4/7 weeks of
amenorrhea from a bichorial-biamniotic twin pregnancy for placental
abruption and fetal bradycardia. The mother had hemorrhagic shock due to
placental detachment. The baby was initially hospitalized in neonatology
on CPAP, which might be weaned later. Blood tests showed poor neonatal
adaptation with pHs of 6.79 and 7.04 with lactates at 18 and Apgar at
0/0/1. The patient had severe asphyxia with hypoxic-ischaemic
encephalopathy and multiorgan involvement. Despite immediate
resuscitation and a recovery of the heart rhythm at 15 minutes of life,
the clinical neurological evolution was unfavorable. The newborn died
after 2 days of life. The outcome of the event Death neonatal was
reported as fatal and the outcome of the rest of the events is reported
as recovered. The reporter considered the events as unlikely related to
the vaccine. The sponsor considers the events as not related to the
vaccine due to long latency and etiopathogenesis of the events that were
triggered by placental abruption. The benefit-risk relationship of
COVID-19 Vaccine Moderna is not affected by this report.; Reported
Cause(s) of Death: Early neonatal death
VAERS ID: 2757685 (history)
Form: Version 2.0
Age:
Sex: Female
Location: Foreign
Vaccinated: 2022-01-06
Onset: 2022-01-26
Days after vaccination: 20
Submitted: 0000-00-00
Entered: 2024-03-28
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ACB5318
/ 3 - / -
Administered by: Other Purchased by: ?
Symptoms: Abnormal behaviour, Apathy, Asthenia, Cardiovascular disorder,
Death, Dementia, Fatigue, Gait disturbance, Neuralgia, Peripheral
swelling, Rash vesicular
SMQs:, Cardiac failure (broad), Angioedema (broad), Peripheral
neuropathy (narrow), Anticholinergic syndrome (broad), Dementia
(narrow), Parkinson-like events (broad), Psychosis and psychotic
disorders (broad), Guillain-Barre syndrome (broad), Noninfectious
encephalitis (broad), Noninfectious encephalopathy/delirium (broad),
Noninfectious meningitis (broad), Extravasation events (injections,
infusions and implants) (broad), Hostility/aggression (broad),
Haemodynamic oedema, effusions and fluid overload (narrow),
Cardiomyopathy (broad), Depression (excl suicide and self injury)
(broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and
systemic symptoms syndrome (broad), Hypoglycaemia (broad)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2757732 (history)
Form: Version 2.0
Age:
Sex: Female
Location: Foreign
Vaccinated: 2023-12-08
Onset: 2023-12-08
Days after vaccination: 0
Submitted: 0000-00-00
Entered: 2024-03-28
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN
/ 1 - / OT
FLUX: INFLUENZA (SEASONAL) (NO BRAND NAME) / UNKNOWN MANUFACTURER
UNKNOWN / UNK - / OT
Administered by: Other Purchased by: ?
Symptoms: Congenital central nervous system anomaly, Exposure during
pregnancy
SMQs:, Congenital, familial and genetic disorders (narrow), Pregnancy,
labour and delivery complications and risk factors (excl abortions and
stillbirth) (narrow)
Life Threatening? No
Birth Defect? Yes
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: VENTOLINE [SALBUTAMOL SULFATE]
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2758318 (history)
Form: Version 2.0
Age:
Sex: Unknown
Location: Foreign
Vaccinated: 0000-00-00
Onset: 0000-00-00
Submitted: 0000-00-00
Entered: 2024-04-01
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / -
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK
- / -
Administered by: Unknown Purchased by: ?
Symptoms: Death, Illness, Immunisation reaction
SMQs:
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUMODERNATX, INC.MOD20237
Write-up: Died; Illness; serious side effects; This spontaneous case was
reported by a consumer and describes the occurrence of DEATH (Died),
ILLNESS (Illness) and IMMUNISATION REACTION (serious side effects) in a
patient of an unknown age and gender who received mRNA-1273 BIVALENT
222 (SPIKEVAX BIVALENT ORIGINAL / OMICRON BA.4-5) for COVID-19
immunization. Co-suspect product included non-company product
TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19
immunization. No Medical History information was reported. On an unknown
date, the patient received dose of mRNA-1273 BIVALENT .222 (SPIKEVAX
BIVALENT ORIGINAL / OMICRON BA.4-5) (unknown route) 1 dosage form and
dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1
dosage form. On an unknown date, the patient experienced DEATH (Died)
(seriousness criteria death and medically significant), ILLNESS
(Illness) (seriousness criterion medically significant) and IMMUNISATION
REACTION (serious side effects) (seriousness criterion medically
significant). The patient died on an unknown date. The cause of death
was not reported. It is unknown if an autopsy was performed. At the time
of death, ILLNESS (Illness) and IMMUNISATION REACTION (serious side
effects) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222
(SPIKEVAX BIVALENT ORIGINAL / OMICRON BA.4-5) (Unknown), the reporter
considered DEATH (Died), ILLNESS (Illness) and IMMUNISATION REACTION
(serious side effects) to be possibly related. No concomitant
medications were reported. No treatment medications were reported. The
Agency Reference Number was reported as AU-TGA-0000803921. Company
comment: This case concerns patient of unknown age and gender, with no
medical history information reported, who experienced the unexpected
serious fatal (death and medically significant) event of death (died)
and unexpected serious (medically significant) events of illness and
immunization reaction (described as serious side effects). The events
occurred on an unknown date. Temporal association with a dose of
Spikevax Bivalent .222 (Original/Omicron BA.4/5) is unclear. The cause
of death was not reported. It is unknown if an autopsy was performed. No
further information about the events was provided. The benefit-risk
relationship of Spikevax Bivalent .222 (Original/Omicron BA.4/5) is not
affected by this report. Most recent FOLLOW-UP information incorporated
above includes: On 01-Mar-2024: Non-significant follow up received
contains AER number added. On 28-Mar-2024: Significant follow up
received included : Secondary reporter added, suspect vaccine coding
updated, events verbatim updated, seriousness criteria of fatal only
retained for event death and case received from was updated, references
added, reporter causality of all events updated to possible.; Reported
Cause(s) of Death: Unknown cause of death
VAERS ID: 2758485 (history)
Form: Version 2.0
Age:
Sex: Male
Location: Foreign
Vaccinated: 2022-04-28
Onset: 0000-00-00
Submitted: 0000-00-00
Entered: 2024-04-01
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH 1F1046A
/ 4 - / -
Administered by: Other Purchased by: ?
Symptoms: Amyotrophic lateral sclerosis
SMQs:
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 2023-06-18
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2758486 (history)
Form: Version 2.0
Age:
Sex: Female
Location: Foreign
Vaccinated: 2021-12-13
Onset: 2021-12-20
Days after vaccination: 7
Submitted: 0000-00-00
Entered: 2024-04-01
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH SDCH8 /
3 - / -
Administered by: Other Purchased by: ?
Symptoms: Cerebral thrombosis, Cerebrovascular accident, Ophthalmic
vascular thrombosis, Visual impairment
SMQs:, Anticholinergic syndrome (broad), Ischaemic central nervous
system vascular conditions (narrow), Haemorrhagic central nervous system
vascular conditions (narrow), Embolic and thrombotic events, vessel type
unspecified and mixed arterial and venous (narrow), Glaucoma (broad),
Optic nerve disorders (broad), Lens disorders (broad), Retinal disorders
(broad), Hypoglycaemia (broad)
Life Threatening? Yes
Birth Defect? No
Died? Yes
Date died: 2024-01-15
Days after onset: 756
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
VAERS ID: 2758741 (history)
Form: Version 2.0
Age:
Sex: Female
Location: Foreign
Vaccinated: 2021-11-09
Onset: 0000-00-00
Submitted: 0000-00-00
Entered: 2024-04-02
Vaccination / Manufacturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH SDEJ8 /
2 - / OT
Administered by: Other Purchased by: ?
Symptoms: Infarction, Maternal exposure during pregnancy, Thrombosis
SMQs:, Myocardial infarction (broad), Embolic and thrombotic events,
vessel type unspecified and mixed arterial and venous (narrow),
Thrombophlebitis (broad), Pregnancy, labour and delivery complications
and risk factors (excl abortions and stillbirth) (narrow)
Life Threatening? No
Birth Defect? No
Died? Yes
Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIO FORTE [CYANOCOBALAMIN;FOLIC ACID;POTASSIUM
IODIDE]; PARACETAMOL
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:
Write-up:
W USA zalecają szczepionkę na COVID-19 dla każdego. Eksperci: Amerykanie nie chc